Non Muscle Myosin II: Vital for Cell Adhesion and Motility
Explore the essential role of non-muscle myosin II in coordinating cell adhesion, motility, and tissue organization through its interactions with actin and regulatory pathways.
Explore the essential role of non-muscle myosin II in coordinating cell adhesion, motility, and tissue organization through its interactions with actin and regulatory pathways.
Cells rely on precise mechanical forces to move, adhere to surfaces, and maintain structural integrity. Non-muscle myosin II (NMII) is a key molecular motor that generates contractile forces by interacting with actin filaments, influencing numerous cellular processes. Its regulation of adhesion and motility is essential for tissue development, immune responses, and wound healing. Disruptions in its function are linked to diseases such as cancer and developmental disorders.
NMII is a hexameric motor protein composed of two heavy chains, two essential light chains, and two regulatory light chains. The heavy chains contain a motor domain responsible for ATP hydrolysis and actin binding, a coiled-coil rod domain that facilitates dimerization, and a non-helical tailpiece that contributes to filament assembly. This organization enables NMII to form bipolar filaments necessary for generating contractile forces within the cytoskeleton. Unlike muscle myosin II, which assembles into highly ordered thick filaments, NMII filaments are smaller and more dynamic, allowing rapid reorganization in response to cellular needs.
Filament formation is governed by conformational changes in the tail domain. In its inactive state, the tail folds onto the motor domain, preventing ATPase activity and actin binding. Phosphorylation of the regulatory light chains induces a conformational shift, exposing the motor domains and promoting filament assembly. This regulation allows NMII to transition between inactive monomeric and active filamentous states, ensuring precise control over contractile force generation.
Mammals possess three NMII isoforms—NMIIA, NMIIB, and NMIIC—each with distinct mechanical properties. NMIIA filaments are highly dynamic, assembling and disassembling rapidly for transient contractile events. NMIIB filaments provide sustained tension for processes requiring prolonged force application. NMIIC combines characteristics of both, contributing to specialized functions. The differential distribution and mechanical properties of these isoforms allow cells to fine-tune contractile forces based on physiological demands.
NMII generates contractile forces through a cyclical interaction with actin filaments, driven by ATP hydrolysis and conformational changes in its motor domains. ATP binding induces detachment from actin, resetting the motor for a new cycle. Hydrolysis triggers a conformational shift, positioning the myosin head for actin binding. Upon phosphate release, a power stroke occurs, converting chemical energy into mechanical force that slides actin filaments.
Actin filament organization dictates NMII’s contractile function. In antiparallel arrays, NMII filaments pull actin filaments together, driving contraction. In parallel arrangements, NMII activity generates tension without significant shortening. These interactions enable localized contractility, such as during lamellipodial retraction, and large-scale cytoskeletal rearrangements, such as stress fiber formation. NMII also crosslinks actin filaments into bundles, enhancing mechanical integrity where sustained tension is required.
Regulatory proteins modulate NMII’s interaction with actin. Tropomyosin stabilizes actin filaments and alters NMII binding affinity, affecting contractile efficiency. Actin-binding proteins such as filamin and α-actinin organize actin networks to either promote or restrict NMII activity. Myosin phosphatase dephosphorylates NMII’s regulatory light chain, reducing actin binding and contractility. Conversely, kinases such as ROCK and MLCK enhance NMII-actin interactions by increasing phosphorylation, promoting filament assembly and sustained force generation.
Cells rely on adhesion to interact with their surroundings, maintain structural integrity, and transmit mechanical forces. NMII regulates the balance between adhesion stability and cytoskeletal contractility. By generating tension, NMII reinforces adhesion sites, ensuring mechanical coupling between the cell and the extracellular matrix (ECM). The strength and organization of these adhesion complexes influence migration, differentiation, and tissue architecture.
Focal adhesion formation and maturation depend on NMII-mediated contractile forces. Integrins cluster at the membrane, forming nascent adhesions that require actin polymerization for stabilization. NMII-generated tension strengthens integrin-actin linkages, recruiting additional adhesion-associated proteins to transform transient contacts into robust focal adhesions. NMII activity determines whether adhesions remain dynamic for rapid responses or become more stable for long-term attachment.
NMII also regulates cell-cell adhesion by modulating adherens junctions, which rely on actin cytoskeletal tension to maintain intercellular connectivity. NMII-generated forces promote cadherin clustering and junctional maturation, essential for epithelial barrier function and collective cell behavior. NMII isoforms contribute differently, with NMIIA supporting rapid adhesion remodeling and NMIIB providing sustained contractile support in stable junctions.
NMII contractile activity is controlled by phosphorylation, which dictates its assembly, localization, and interaction with actin. Phosphorylation of the regulatory light chain (RLC) modulates NMII’s conformational state and motor function. Enzymes such as myosin light chain kinase (MLCK), Rho-associated protein kinase (ROCK), and protein kinase C (PKC) phosphorylate RLC at key serine and threonine residues, enhancing filament formation and actin binding. This activation allows NMII to transition from an inactive monomeric state to an extended, filamentous configuration capable of generating contractile forces.
Monophosphorylation initiates filament assembly, while diphosphorylation amplifies contractile force production. Different kinase signaling pathways regulate NMII dynamics based on cellular context. ROCK-mediated phosphorylation is associated with sustained contractility and stress fiber formation, while MLCK activity contributes to rapid, localized force generation. Phosphatases such as myosin phosphatase counterbalance kinase activity, ensuring NMII-mediated contraction remains responsive to external signals. Dysregulated phosphorylation disrupts cytoskeletal mechanics, altering cellular tension and mechanical homeostasis.
Cell motility is fundamental to development, wound healing, and cancer metastasis. NMII facilitates movement by generating contractile forces that drive cytoskeletal rearrangements and coordinate adhesion dynamics. Its regulation of actin filament organization and tension enables cells to transition between movement modes.
In mesenchymal migration, NMII-generated forces promote the formation and retraction of actin-rich protrusions, such as lamellipodia and filopodia, which help cells navigate complex environments. Contractile forces also assist in adhesion disassembly at the cell rear, ensuring forward progression. NMII fine-tunes cytoskeletal tension, allowing cells to adjust motility in response to extracellular signals.
NMII also plays a role in collective cell movement, where groups of cells coordinate motility to maintain tissue integrity. In epithelial sheet migration, NMII-generated contractility at cell-cell junctions ensures cohesive movement. In amoeboid migration, used in confined environments, NMII-driven actomyosin contractility replaces adhesion-based traction. Dysregulated NMII activity impairs motility, contributing to invasive cancer progression and defective tissue repair.
Coordinated cellular forces shape tissues during development and maintain structural integrity. NMII regulates mechanical tension within and between cells, ensuring proper tissue architecture. In epithelial tissues, NMII-mediated contractility maintains apical-basal polarity by reinforcing adhesion complexes and organizing the actin cytoskeleton. This tension-driven regulation is necessary for barrier function and morphogenesis.
During embryonic development, NMII-generated forces drive processes such as convergent extension, which elongates tissues by coordinating cell rearrangement. By generating contractile forces at cell-cell junctions, NMII facilitates intercalation, essential for shaping structures like the neural tube and cardiac tissue. In mature tissues, NMII adjusts cytoskeletal tension in response to external forces, preserving mechanical homeostasis. Disruptions in NMII activity can lead to developmental abnormalities and tissue disorganization.
Aberrant NMII function is implicated in cancer, cardiovascular disorders, and neurodevelopmental diseases. In cancer, NMII influences tumor cell invasion and metastasis by modulating cytoskeletal contractility and adhesion turnover. Increased NMIIA expression enhances migratory capacity in aggressive cancers, facilitating extracellular matrix remodeling. Conversely, NMII dysfunction can weaken adhesion stability, promoting tumor cell detachment and dissemination. The balance between NMII isoforms affects tumor progression, with altered expression correlating with metastatic potential.
NMII dysfunction is also linked to congenital disorders affecting tissue development. Mutations in MYH9, the gene encoding NMIIA, cause MYH9-related disorders, leading to platelet abnormalities, nephropathy, and hearing loss due to defective cytoskeletal mechanics. In neurological conditions, NMII-mediated contractility supports neurite outgrowth and synaptic plasticity, with dysfunction contributing to neurodevelopmental disorders such as autism spectrum disorder. NMII is also implicated in fibrotic diseases, where excessive actomyosin contractility promotes pathological tissue stiffening. Its diverse roles in disease highlight its importance in maintaining cellular and tissue homeostasis.